Brainstorm Cell Therapeutics Inc. (BCLI)
Stock-Based Compensation
$2.68M
TTM · Period ending: · USD
BCLI Stock-Based Compensation
Latest reported$2.68Mperiod ending
Latest reported$2.68Mperiod ending
BCLI TTM Stock-Based Comp ($0.00 → $2.68M)
TTM stock-based compensation
High-resolution chart · PNG
BCLI stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 2,677,000 | |
| 936,000 | |
| 1,520,000 | |
| 1,585,000 | |
| 1,606,000 | |
| 1,297,000 | |
| 750,000 | |
| 542,000 | |
| 912,000 | |
| 1,706,000 | |
| 1,540,000 | |
| 1,917,000 | |
| 1,764,000 | |
| 1,181,000 | |
| 1,682,000 | |
| 1,945,000 | |
| 1,746,000 | |
| 1,799,000 | |
| 1,584,000 | |
| 1,306,000 | |
| 2,127,000 | |
| 2,460,000 | |
| 2,560,000 | |
| 2,380,000 | |
| 1,580,000 | |
| 842,000 | |
| 764,000 | |
| 901,000 | |
| 919,000 | |
| 1,002,000 | |
| 917,000 | |
| 754,000 | |
| 734,000 | |
| 655,000 | |
| 554,000 | |
| 397,000 | |
| 353,000 | |
| 558,000 | |
| 635,000 | |
| 516,000 | |
| 632,000 | |
| 691,000 | |
| 835,000 | |
| 1,599,000 | |
| 1,592,000 | |
| 1,447,000 | |
| 1,222,000 | |
| 813,000 | |
| 458,000 | |
| 593,000 | |
| 674,000 | |
| 559,000 | |
| 761,000 | |
| 586,000 | |
| 560,000 | |
| 789,000 | |
| 1,005,000 | |
| 1,285,000 | |
| 1,135,000 | |
| 786,000 | |
| 514,000 | |
| 185,000 | |
| 254,000 | |
| 254,000 | |
| 183,000 | |
| 96,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,173,547 | |
| 1,173,547 | |
| 1,173,547 | |
| 1,173,547 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |